EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against Shigella flexneri

Yang W Huan, Vincenzo Torraca iD, Russell Brown, Jidapha Fa-Arun, Sydney L Miles, Diego A Oyarzún iD, Serge Mostowy iD, Baojun Wang iD

ACS Synthetic Biology · 17.03.2023 · 12 (3) · 709-721

DOI: 10.1021/acssynbio.2c00465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 20.02.2023. Verfasst von Yang W Huan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, U.K. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Anti-Infective Agents. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of clustered, regularly interspaced, short palindromic repeats (CRISPR) and the Cas9 RNA-guided nuclease provides unprecedented opportunities to selectively kill specific populations or species of bacteria. However, the use of CRISPR-Cas9 to clear bacterial infections in vivo is hampered by the inefficient delivery of cas9 genetic constructs into bacterial cells. Here, we use a broad-host-range P1-derived phagemid to deliver the CRISPR-Cas9 chromosomal-targeting system into Escherichia coli and the dysentery-causing Shigella flexneri to achieve DNA sequence-specific killing of targeted bacterial cells. We show that genetic modification of the helper P1 phage DNA packaging site (pac) significantly enhances the purity of packaged phagemid and improves the Cas9-mediated killing of S. flexneri cells. We further demonstrate that P1 phage particles can deliver chromosomal-targeting cas9 phagemids into S. flexneri in vivo using a zebrafish larvae infection model, where they significantly reduce the bacterial load and promote host survival. Our study highlights the potential of combining P1 bacteriophage-based delivery with the CRISPR chromosomal-targeting system to achieve DNA sequence-specific cell lethality and efficient clearance of bacterial infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsAnti-Infective AgentsGene EditingBacteriophage P1ZebrafishShigella flexneriAnimals

Stichwörter der Autor:innen

CRISPR-Cas9P1 bacteriophageShigella flexneriantimicrobialphagemid

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, U.K.
  • Department of Infection Biology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, U.K.
  • School of Life Sciences, University of Westminster, London W1B 2HW, U.K.
  • School of Informatics, University of Edinburgh, Edinburgh EH8 9AB, U.K.
  • College of Chemical and Biological Engineering & ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou 310058, China.
  • Research Center for Biological Computation, Zhejiang Laboratory, Hangzhou 311100, China.

ORCID-Profile: Vincenzo Torraca, Diego A Oyarzún, Serge Mostowy, Baojun Wang

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
  • UK Research and Innovation
  • Darwin Trust of Edinburgh
  • Central University Basic Research Fund of China
  • Bill and Melinda Gates Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Huan, Y. W., Torraca, V., Brown, R., Fa-Arun, J., Miles, S. L., Oyarzún, D. A., Mostowy, S., & Wang, B. (2023). P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against Shigella flexneri. ACS Synthetic Biology, 12(3), 709-721. https://doi.org/10.1021/acssynbio.2c00465

Vancouver

Huan YW, Torraca V, Brown R, Fa-Arun J, Miles SL, Oyarzún DA, et al. P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against Shigella flexneri. ACS Synthetic Biology. 2023;12(3):709-721. doi:10.1021/acssynbio.2c00465

BibTeX
@article{Huan2023,
  author = {Huan, Yang W and Torraca, Vincenzo and Brown, Russell and Fa-Arun, Jidapha and Miles, Sydney L and Oyarzún, Diego A and Mostowy, Serge and Wang, Baojun},
  title = {P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against Shigella flexneri},
  journal = {ACS Synthetic Biology},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {709--721},
  doi = {10.1021/acssynbio.2c00465}
}
Kostenlos starten →